Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 11890715)

Published in Clin Immunol on March 01, 2002

Authors

Violeta Rus1, Sergei P Atamas, Valentina Shustova, Irina G Luzina, Florin Selaru, Laurence S Magder, Charles S Via

Author Affiliations

1: Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Maryland Medical School, Baltimore, Maryland 21201, USA. vrus@umaryland.edu

Articles citing this

Microarray analysis of gene expression in lupus. Arthritis Res Ther (2003) 1.67

Interferon-inducible gene 202b controls CD8(+) T cell-mediated suppression in anti-DNA Ig peptide-treated (NZB × NZW) F1 lupus mice. Genes Immun (2011) 1.41

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification. BMC Cancer (2003) 1.27

Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients. Arthritis Res Ther (2008) 1.23

Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm (2009) 1.17

Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Natl Acad Sci U S A (2007) 1.14

Gene expression signatures for autoimmune disease in peripheral blood mononuclear cells. Arthritis Res Ther (2004) 1.14

Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. Ann Rheum Dis (2004) 1.13

Biomarkers for type 1 diabetes. Int J Clin Exp Med (2008) 0.98

Detection of gene expression in an individual cell type within a cell mixture using microarray analysis. PLoS One (2009) 0.92

Immunosuppressive therapy modulates T lymphocyte gene expression in patients with systemic lupus erythematosus. Immunology (2004) 0.87

Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches. J Biomed Biotechnol (2010) 0.85

Interleukin-1 gene cluster and IL-1 receptor polymorphisms in Iranian patients with systemic lupus erythematosus. Rheumatol Int (2013) 0.84

Systemic lupus erythematosus diagnostics in the 'omics' era. Int J Clin Rheumtol (2013) 0.84

Antigen-specific gene expression profiles of peripheral blood mononuclear cells do not reflect those of T-lymphocyte subsets. Clin Diagn Lab Immunol (2004) 0.83

Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy. J Biomed Biotechnol (2010) 0.82

Cytokine-induced monocyte characteristics in SLE. J Biomed Biotechnol (2010) 0.82

Microfluidics for T- lymphocyte cell separation and inflammation monitoring in burn patients. Clin Transl Sci (2011) 0.82

Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) on kidney tissue from systemic lupus erythematosus (SLE) patients. Clin Exp Med (2013) 0.81

Meta-analysis of associations of IL1 receptor antagonist and estrogen receptor gene polymorphisms with systemic lupus erythematosus susceptibility. PLoS One (2014) 0.80

Elevated serum TRAIL levels in scleroderma patients and its possible association with pulmonary involvement. Clin Rheumatol (2012) 0.80

Gene expression profiling: from microarrays to medicine. J Clin Immunol (2004) 0.80

Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology. Mediators Inflamm (2005) 0.79

Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma). Clin Exp Immunol (2010) 0.78

Genome-wide gene expression profiling reveals unsuspected molecular alterations in pemphigus foliaceus. Immunology (2014) 0.76

Clinical Application of a Modular Genomics Technique in Systemic Lupus Erythematosus: Progress towards Precision Medicine. Int J Genomics (2016) 0.75

ArraySolver: an algorithm for colour-coded graphical display and Wilcoxon signed-rank statistics for comparing microarray gene expression data. Comp Funct Genomics (2004) 0.75

RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities. PLoS One (2016) 0.75

Articles by these authors

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum (2012) 6.85

Hepatitis c in a community in Upper Egypt: risk factors for infection. Am J Trop Med Hyg (2002) 2.12

Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset. J Rheumatol (2010) 1.89

Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) (2006) 1.87

Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database. Transplantation (2008) 1.80

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. BMJ (2002) 1.68

Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database. Liver Transpl (2009) 1.65

Molecular epidemiology of tuberculosis in a low- to moderate-incidence state: are contact investigations enough? Emerg Infect Dis (2002) 1.64

The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum (2005) 1.59

The SEEK model of pediatric primary care: can child maltreatment be prevented in a low-risk population? Acad Pediatr (2012) 1.56

Intrafamilial transmission of hepatitis C in Egypt. Hepatology (2005) 1.53

Dental visits to hospital emergency departments by adults receiving Medicaid: assessing their use. J Am Dent Assoc (2002) 1.49

Roles of T lymphocytes in pulmonary fibrosis. J Leukoc Biol (2007) 1.42

Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus. Rheumatol Int (2013) 1.41

Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene (2002) 1.39

Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts. Am J Respir Cell Mol Biol (2003) 1.38

Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair (2012) 1.37

Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. Cancer Res (2002) 1.37

Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort. Arthritis Rheum (2012) 1.34

Identifying children at high risk for a child maltreatment report. Child Abuse Negl (2011) 1.29

Countywide school-based influenza immunization: direct and indirect impact on student absenteeism. Pediatrics (2008) 1.29

Complex regulation of pulmonary inflammation and fibrosis by CCL18. Am J Pathol (2007) 1.28

Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol (2004) 1.28

Centrilobular emphysema combined with pulmonary fibrosis results in improved survival. Fibrogenesis Tissue Repair (2011) 1.23

Gene expression in bronchoalveolar lavage cells from scleroderma patients. Am J Respir Cell Mol Biol (2002) 1.23

A pilot study of the effectiveness of a school-based influenza vaccination program. Pediatrics (2005) 1.22

Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. Gastroenterology (2002) 1.21

Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol (2002) 1.20

Regulation of inflammation by interleukin-4: a review of "alternatives". J Leukoc Biol (2012) 1.20

Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology (2013) 1.18

An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients. Arch Gen Psychiatry (2002) 1.16

Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion. J Immunol (2012) 1.15

Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis. J Immunol (2008) 1.13

Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt. Trans R Soc Trop Med Hyg (2008) 1.12

Macrophages produce TGF-beta-induced (beta-ig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts. J Immunol (2008) 1.11

Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients. Arthritis Rheum (2003) 1.10

Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro. Clin Diagn Lab Immunol (2005) 1.09

Differential requirement for IFN-gamma in CTL maturation in acute murine graft-versus-host disease. J Immunol (2004) 1.09

Regulation of pulmonary inflammation and fibrosis through expression of integrins alphaVbeta3 and alphaVbeta5 on pulmonary T lymphocytes. Arthritis Rheum (2009) 1.07

Antenatal Ureaplasma urealyticum respiratory tract infection stimulates proinflammatory, profibrotic responses in the preterm baboon lung. Pediatr Res (2006) 1.07

Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. J Med Virol (2009) 1.05

In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function. J Immunol (2002) 1.05

Associations between breast milk viral load, mastitis, exclusive breast-feeding, and postnatal transmission of HIV. Clin Infect Dis (2010) 1.04

Induction of prolonged infiltration of T lymphocytes and transient T lymphocyte-dependent collagen deposition in mouse lungs following adenoviral gene transfer of CCL18. Arthritis Rheum (2006) 1.04

Gender disparity in liver transplant waiting-list mortality: the importance of kidney function. Liver Transpl (2010) 1.03

Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol (2012) 1.03

CCL18-stimulated upregulation of collagen production in lung fibroblasts requires Sp1 signaling and basal Smad3 activity. J Cell Physiol (2006) 1.02

Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum (2013) 1.01

Mother-to-child transmission of HIV-1: strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanisms. J Acquir Immune Defic Syndr (2004) 1.01

Predictors of carotid atherosclerosis in systemic lupus erythematosus. J Rheumatol (2006) 1.01

Early risk factors for pregnancy loss in lupus. Obstet Gynecol (2006) 1.00

Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade. Psychiatr Serv (2013) 1.00

Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling. J Immunol (2002) 1.00

Role of exopolysaccharide, the rugose phenotype and VpsR in the pathogenesis of epidemic Vibrio cholerae. FEMS Microbiol Lett (2004) 0.99

Interleukin-33 potentiates bleomycin-induced lung injury. Am J Respir Cell Mol Biol (2013) 0.98

Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. J Rheumatol (2009) 0.98

PKCalpha mediates CCL18-stimulated collagen production in pulmonary fibroblasts. Am J Respir Cell Mol Biol (2006) 0.98

CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus. J Immunol (2008) 0.97

Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs.-host disease. Exp Mol Pathol (2005) 0.97

The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. J Rheumatol (2011) 0.96

Transmission of hepatitis C virus between parents and children. Am J Trop Med Hyg (2006) 0.95

T cell TRAIL promotes murine lupus by sustaining effector CD4 Th cell numbers and by inhibiting CD8 CTL activity. J Immunol (2007) 0.95

High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial. Arthritis Rheum (2010) 0.94

Apoptotic splenocytes drive the autoimmune response to poly(ADP-ribose) polymerase 1 in a murine model of lupus. J Immunol (2007) 0.94

Seasonal variation in the activity of systemic lupus erythematosus. J Rheumatol (2012) 0.94

Dietary supplementation with d-tagatose in subjects with type 2 diabetes leads to weight loss and raises high-density lipoprotein cholesterol. Nutr Res (2010) 0.93

Adolescent mothers leaving multigenerational households. J Clin Child Adolesc Psychol (2009) 0.93

Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis. Expert Rev Respir Med (2015) 0.92

NEU1 sialidase expressed in human airway epithelia regulates epidermal growth factor receptor (EGFR) and MUC1 protein signaling. J Biol Chem (2012) 0.92

Hospital admissions associated with nontraumatic dental emergencies in a Medicaid population. Am J Emerg Med (2003) 0.92

How robust are health plan quality indicators to data loss? A Monte Carlo simulation study of pediatric asthma treatment. Health Serv Res (2003) 0.92

Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C. J Hepatol (2007) 0.91

Gene expression profiling in peripheral blood mononuclear cells from lupus patients with active and inactive disease. Clin Immunol (2004) 0.91

Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children. Trans R Soc Trop Med Hyg (2010) 0.91

Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus. Rheumatology (Oxford) (2011) 0.90

Targeted deletion of Jun/AP-1 in alveolar epithelial cells causes progressive emphysema and worsens cigarette smoke-induced lung inflammation. Am J Pathol (2012) 0.89

Alternatively spliced variants of interleukin-4 promote inflammation differentially. J Leukoc Biol (2011) 0.89

Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis. J Inflamm Res (2013) 0.89

Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells. J Immunol (2003) 0.89

Hypermethylation of HPP1 is associated with hMLH1 hypermethylation in gastric adenocarcinomas. Cancer Res (2002) 0.88

Survival associated pathway identification with group Lp penalized global AUC maximization. Algorithms Mol Biol (2010) 0.88

The safe environment for every kid model: impact on pediatric primary care professionals. Pediatrics (2011) 0.87

Agricultural workers and urinary bladder cancer risk in Egypt. Arch Environ Occup Health (2014) 0.87

Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression. Clin Immunol (2010) 0.87

Survey of culture, goldengate assay, universal biosensor assay, and 16S rRNA Gene sequencing as alternative methods of bacterial pathogen detection. J Clin Microbiol (2013) 0.87

A regional system of stroke care provides thrombolytic outcomes comparable with the NINDS stroke trial. Ann Emerg Med (2008) 0.86

Fas expression on antigen-specific T cells has costimulatory, helper, and down-regulatory functions in vivo for cytotoxic T cell responses but not for T cell-dependent B cell responses. J Immunol (2008) 0.86

Splice isoforms of human interleukin-4 are functionally active in mice in vivo. Immunology (2011) 0.86

Noncalcified coronary plaque in systemic lupus erythematosus. J Rheumatol (2010) 0.85

Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease. Clin Immunol (2005) 0.85